The place of migraine as a channelopathy

Current Opinion in Neurology

Volumn 11, Issue 3, 1998, Pages 217-226

  Ptáček, Louis J ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CHLORIDE CHANNEL; SODIUM CHANNEL;

CELL MEMBRANE DEPOLARIZATION; CONVULSION; DYSKINESIA; EPILEPSY; HUMAN; LONG QT SYNDROME; MIGRAINE; MYASTHENIA; MYOTONIA; NEUROLOGIC DISEASE; NEUROPHYSIOLOGY; REVIEW;

CHLORIDE CHANNELS; EPILEPSY; HUMANS; ION CHANNELS; MIGRAINE DISORDERS; MYOTONIA; PARALYSES, FAMILIAL PERIODIC; PERIODICITY; SODIUM CHANNELS;

EID: 0031837371     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199806000-00005     Document Type: Review

References (60)

1. Ptácek LJ, Johnson KJ, Griggs RC. Genetics and physiology of the myotonic muscle disorders. N Engl J Med 1993; 328:482-489.
2. Ptácek LJ. Channelopathies: ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system. Neuromusc Disord 1997; 7:250-255.
3. Lehmann Horn F, Kuther G, Ricker K, Grate P, Ballanyi K, Rudel R. Adynamia episodica hereditaria with myotonia : a non-inactivating sodium current and the effect of extracellular pH. Muscle Nerve 1987; 10:363-374.
4. Ptácek LJ, Trimmer JS, Agnew WS, Roberts JW, Petajan JH, Leppert M. Paramyotonia congenita and hyperkalemic periodic paralysis map to the same sodium-channel gene locus. Am J Hum Genet 1991; 49:851-854.
5. Cannon SC, Brown RH Jr, Corey DP. A sodium channel defect in hyperkalemic periodic paralysis: potassium-induced failure of inactivation. Neuron 1991; 6:619-626.
6. Lehmann Horn F, Rudel R, Ricker K. Membrane defects in paramyotonia congenita (Eulenburg). Muscle Nerve 1987; 10:633-641.
7. Tahmoush AJ, Schaller KL, Zhang P, Hyslop T, Heiman Patterson T, Caldwell JH. Muscle sodium channel inactivation defect in paramyotonia congenita with the thr1313met mutation. Neuromusc Disord 1994; 4:447-454.
8. Ptáček LJ, Griggs RC. Familial periodic paralyses. In: Andreoli T (editor). The molecular biology of membrane transport disorders. 3rd ed. New York: Plenum; 1996; pp 625-642.
9. Ptáček LJ, George AL Jr, Griggs RC, Tawil R, Kallen RG, Barchi RL, et al. Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 1991; 67:1021-1027.
10. + channel alpha-subunit in hyperkalaemic periodic paralysis. Nature 1991; 354:387-389.
11. McClatchey AI, Van den Bergh P, Pericak Vance MA, Raskind W, Verellen C, McKenna Yasek D, et al. Temperature-sensitive mutations in the III-IV cytoplasmic loop region of the skeletal muscle sodium channel gene in paramyotonia congenita. Cell 1992; 68:769-774.
12. Ptácek LJ, George AL, Jr., Barchi RL, Griggs RC, Riggs JE, Robertson M, Leppert MF. Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron 1992; 8:891-897.
13. Cannon SC, Strittmatter SM. Functional expression of sodium channel mutations identified in families with periodic paralysis. Neuron 1993; 10:317-326.
14. + channel mutation causing hyperkalemic periodic paralysis. Neuron 1993; 10:667-678.
15. Chahine M, George AL, Jr., Zhou M, Ji S, Sun W, Barchi RL, Horn R. Sodium channel mutations in paramyotonia congenita uncouple inactivation from activation. Neuron 1994; 12:281-294.
16. Yang N, Ji S, Zhou M, Ptácek LJ, Barchi RL, Horn R, George AL, Jr. Sodium channel mutations in paramyotonia congenita exhibit similar biophysical phenotypes in vitro. Proc Natl Acad Sci USA 1994; 91:12785-12789.
17. + channel by the V1589M mutation. J Physiol (Lond) 1994; 478(Pt 3):395-402.
18. Ptáček LJ, Tawil R, Griggs RC, Engel AG, Layzer RB, Kwiecinski H, et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 1994; 77:863-868.
19. Elbaz A, Vale Santos J, Jurkat Rott K, Lapie P, Ophoff RA, Bady B, et al. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3):genotype/phenotype correlations tor two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families. Am J Hum Genet 1995; 56:374-380.
20. Fouad G, Dalakas M, Servedei S, Mendell JR, Van den Bergh P, Angelini C, et al. Genotype-phenotype correlations of DHP receptor alpha-1 gene mutations causing hypokalemic periodic paralysis. Neuromuscular Disorders 1937; 7:33-38.
21. Koch MC, Steinmeyer K, Lorenz C, Ricker K, Wolf F, Otto M, et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 1992; 257:797-800.
22. George AL, Jr., Crackower MA, Abdalla JA, Hudson AJ, Ebers GC. Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita). Nat Genet 1993; 3:305-310.
23. Heine R, George AL, Jr., Pika U, Deymeer F, Rudel R, Lehmann Horn F. Proof of a non-functional muscle chloride channel in recessive myotonia congenita (Becker) by detection of a 4 base pair deletion. Hum Mol Genet 1994; 3:1123-1128.
24. Gronemeier M, Condie A, Prosser J, Steinmeyer K, Jentsch TJ, Jockusch H. Nonsense and missense mutations in the muscular chloride channel gene Clc-1 of myotonic mice. J Biol Chem 1994; 269:5963-5967.
25. Zhang J, George AL, Griggs RC, Fouad GT, Roberts J, Kwiecinski H, et al. Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita. Neurology 1996; 47:993-998.
26. Pusch M, Steinmeyer K, Koch MC, Jentsch TJ. Mutations in dominant human myotonia congenita drastically alter the voltage dependence of the CIC-1 chloride channel. Neuron 1995; 15:1455-1463.
27. Fahlke C, Rosenbohm A, Mitrovic N, George AL, Jr., Rudel R. Mechanism of voltage-dependent gating in skeletal muscle chloride channels. Biophys J 1996; 71:695-706.
28. Fahlke C, Rudel R, Mitrovic N, Zhou M, George AL, Jr. An aspartic acid residue important for voltage-dependent gating of human muscle chloride channels. Neuron 1995; 15:463-472.
29. Browne DL, Gancher ST, Nutt JG, Brunt ER, Smith EA, Kramer P, Litt M. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 1994; 8:136-140.
30. Tawil R, Ptáček LJ, Pavlakis SG, DeVivo DC, Penn AS, Ozdemir C, Griggs RC. Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol 1994; 35:326-330.
31. Joutel A, Bousser M, Biousse V, Labauge P, Chabriat H, Nibbio A, et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 1993; 5:40-45.
32. Marchioni E, Galimberti CA, Soragna D, Ferrandi D, Maurelli M, Ratti MT, et al. Familial hemiplegic migraine versus migraine with prolonged aura: an uncertain diagnosis in a family report. Neurology 1995; 45:33-37.
33. Singh NA, Charlier C, Stauffer D, DuPont BR, Leach RJ, Melis R, et al. •• A novel potassium channel gene. KCNQ2, is mutated in an inherited epilepsy of newborns. Nature Genet 1998; 18:25-29. This paper represents the first strong genetic data implicating an ion channel gene in a human epilepsy, benign familial neonatal convulsions. The gene encodes a voltage-gated potassium channel.
34. ••], the physical map of a second benign familial neonatal convulsion locus was examined for a gene homologous to the BFNC1 potassium channel. A second potassium channel causing a human epilepsy was characterized and shown to be mutated in a family mapping to this locus.
35. Shiang R, Ryan SG, Zhu YZ, Hahn AF, O'Connell P, Wasmuth JJ. Mutations in the alpha1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nature Genet 1993; 5:351-358.
36. Engel AG, Ohno K, Milone M, Wang HL, Nakano S, Bouzat C, et al. New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet 1996; 5:1217-1227.
37. Scheffer IE, Bhatia KP, Lopes Cendes I, Fish DR, Marsden CD. Andermann E, et al. Autosomal dominant nocturnal frontal lobe epilepsy . A distinctive clinical disorder. Brain 1995; 118:61-73.
38. Goodenough D, Fariello R, Annis B, Chun R. Familial and acquired paroxysmal dyskinesias. Arch Neurol 1978; 35:827-831.
39. Mount L, Reback S. Familial paroxysmal choreoathetosis. Arch Neurol Psychiatry 1940; 44:841-847.
40. Fahn S. The paroxysmal dyskinesias. Oxford: Butterworth-Heinemann 1994, pp 310-345.
41. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995; 38:571-579.
42. Ptáček LJ. Channelopathies: Ion Channels and paroxysmal disorders of the Nervous system. In: Genton P, ed. Genetics of Focal Epilepsies. London: John Libbey, 1998; in press.
43. Welch KM, Lewis D. Migraine and epilepsy. Neurol Clin 1997; 15: 107-114.
44. 2+ gene CACNL1A4. Cell 1996; 87:543-552. This publication established the CACNL1A4 gene (a gene homologous to the calcium channel known to cause hypokalemic periodic paralysis: see [18]) as the site of mutation in episodic ataxia type 2 and one form of familial hemiplegic migraine.
45. Ducros A, Joutel A, Vahedi K, Cecillon M, Ferreira A, Bernard E, et al. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity In Process Citation. Ann Neurol 1997; 42:885-90.
46. Gardner K, Barmada MM, Ptáček LJ, Hoffman EP. A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology 1997; 49:1231-1238.
47. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996; 12:17-23.
48. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995; 80:795-803.
49. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80:805-811.
50. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nature Genetics 1997; 17:338-340.
51. Steinliein OK, Mulley JC, Propping P, Wallace RH, Phillips HA, Sutherland GR, et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995; 11:201-203.
52. Ohno K, Wang HL, Milone M, Bren N, Brengman JM, Nakano S, et al. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit. Neuron 1996; 17:157-170.
53. Auburger G, Ratzlaff T, Lunkes A, Nelles H, Leube B, Binkofski F, Kugel H, et al. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probable within 2 cM between D1S443 and D1S197. Genomics 1996; 31:90-94.
54. Fouad GT, Servidei S, Durcan S, Bertini E, Ptáček LJ. A gene for familial paroxysmal dyskinesia (FPD1) maps to chomosome 2q. Am J Hum Genet 1996; 59:135-139.
55. Ducros A, Joutel A, Vahedi K, Cecillon M, Ferreira A, Bernard E, et al. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol 1997; 47:885-890.
56. Russell MB. The genetics of migraine. European Journal of Neurology 1997; 4:2-7.
57. Stewart WF, Staffa J, Lipton RB, Ottman R. Familial risk of migraine: a population-based study. Ann Neurol 1997; 41:166-172.
58. +-channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci USA 1996; 93:2208-2212. Published erratum appears in Proc Natl Acad Sci USA 1996; Aug 6; 93(16):8796.
59. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995; 81:299-307.
60. Shalaby FY, Levesque PC, Yang WP, Little WA, Conder ML, Jenkins-West T, Blanar MA. Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome. Circulation 1997; 96:1733-1736.